全文获取类型
收费全文 | 1479篇 |
免费 | 76篇 |
国内免费 | 147篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 75篇 |
妇产科学 | 14篇 |
基础医学 | 132篇 |
口腔科学 | 22篇 |
临床医学 | 203篇 |
内科学 | 341篇 |
皮肤病学 | 31篇 |
神经病学 | 37篇 |
特种医学 | 363篇 |
外科学 | 85篇 |
综合类 | 26篇 |
一般理论 | 1篇 |
预防医学 | 100篇 |
眼科学 | 24篇 |
药学 | 136篇 |
1篇 | |
肿瘤学 | 61篇 |
出版年
2021年 | 8篇 |
2019年 | 13篇 |
2018年 | 21篇 |
2017年 | 15篇 |
2016年 | 13篇 |
2015年 | 17篇 |
2014年 | 18篇 |
2013年 | 41篇 |
2012年 | 33篇 |
2011年 | 34篇 |
2010年 | 39篇 |
2009年 | 51篇 |
2008年 | 35篇 |
2007年 | 130篇 |
2006年 | 31篇 |
2005年 | 38篇 |
2004年 | 21篇 |
2003年 | 15篇 |
2002年 | 28篇 |
2001年 | 26篇 |
2000年 | 18篇 |
1999年 | 31篇 |
1998年 | 80篇 |
1997年 | 76篇 |
1996年 | 77篇 |
1995年 | 67篇 |
1994年 | 44篇 |
1993年 | 53篇 |
1992年 | 19篇 |
1991年 | 33篇 |
1990年 | 25篇 |
1989年 | 69篇 |
1988年 | 45篇 |
1987年 | 52篇 |
1986年 | 42篇 |
1985年 | 43篇 |
1984年 | 39篇 |
1983年 | 30篇 |
1982年 | 34篇 |
1981年 | 16篇 |
1980年 | 19篇 |
1979年 | 13篇 |
1978年 | 12篇 |
1977年 | 25篇 |
1976年 | 31篇 |
1975年 | 16篇 |
1974年 | 7篇 |
1972年 | 6篇 |
1971年 | 11篇 |
1970年 | 7篇 |
排序方式: 共有1702条查询结果,搜索用时 31 毫秒
71.
目的:观察白藜芦醇对一次性力竭游泳大鼠肝脏组织的作用及发挥作用的最佳口服剂量。方法:实验于2006-05/07在成都体育学院运动医学系动物实验室完成。①实验分组:选取雄性SD大鼠70只,随机分为7组,每组10只,分别为安静对照组,运动对照组,运动 15mg/kg白藜芦醇组,运动 50mg/kg白藜芦醇组,运动 100mg/kg白藜芦醇组,运动 200mg/kg白藜芦醇组,运动 300mg/kg白藜芦醇组。②实验干预:不同剂量白藜芦醇组每天灌胃15,50,100,200,300mg/kg白藜芦醇,安静对照组和运动对照组分别灌胃相同体积的溶媒(二甲亚砜 生理盐水),连续5周。末次给予实验用样品1h后,各运动组每只鼠尾跟部负荷3%体质量铅皮,置于水深50cm、水温(31±1)℃游泳槽中游泳。游泳力竭后即刻,股动脉取血并迅速取出肝组织。③指标检测:赖氏比色法测定血清中谷丙转氨酶活性;邻苯三酚自氧化法测定肝组织超氧化物歧化酶活性;硫代巴比妥酸法测定肝组织丙二醛含量。结果:纳入动物70只,均进入结果分析。①血清谷丙转氨酶活性和肝组织中丙二醛含量:运动对照组显著高于安静对照组,不同剂量白藜芦醇组低于运动对照组(P<0.05或P<0.01)。运动 100,200,300mg/kg白藜芦醇组低于运动 15,50mg/kg白藜芦醇组[谷丙转氨酶活性:(972.36±121.86),(944.36±105.35),(888.34±88.68),(1773.52±89.35),(1377.78±27.01)nkat/L,P<0.01;丙二醛含量:(7.90±2.56),(7.69±3.69),(7.13±2.62),(19.90±2.21),(12.16±1.78)μmol/g,P<0.05]。100,200,300mg/kg白藜芦醇组间差异无显著性。②肝脏组织中超氧化物歧化酶活性:运动对照组显著低于安静对照组,不同剂量白藜芦醇组高于运动对照组(P<0.05或P<0.01)。运动 100,200,300mg/kg白藜芦醇组高于15,50mg/kg白藜芦醇组[(2325.80±163.37),(2379.14±121.86),(2447.16±89.18),(1096.05±120.19),(1514.64±28.17)μkat/g,P<0.01]。结论:①白藜芦醇对力竭性运动大鼠肝脏组织具有保护作用。②100,200,300mg/kg白藜芦醇对肝脏组织发挥保护作用效果优于15,50mg/kg,建议使用100mg/kg白藜芦醇就能达到理想效果。 相似文献
72.
73.
74.
75.
76.
Susana R. Patton Sally Eder Jennifer Schwab Christine M. Sisson 《Journal of pediatric health care》2010,24(6):365-371
ObjectiveInjection site rotation is an important component of insulin administration and is helpful in preventing lipodystrophy in type 1 diabetes (T1DM). We examined the number of injection/infusion sites (sites) used by youth with T1DM and their perceived barriers to using new sites for insulin.MethodsTwo hundred and one youth with T1DM completed a 24-item survey about site rotation practices and barriers to site rotation during a routine diabetes appointment.ResultsFifteen percent of youth reported using at least four distinct sites in their rotation plan, while 22% reported using only one site. A negative correlation was found between number of sites used and the number of perceived barriers endorsed by youth on multiple daily injections. Fear of pain was the most common barrier endorsed by youth.ConclusionMany youth with T1DM may not adhere to an adequate site rotation plan. Regular assessment of insulin sites and counseling regarding adequate site rotation is needed when managing diabetes in youth. Relaxation and distraction may help to reduce youths' fear of pain when rotating to new insulin sites. 相似文献
77.
Baligh Yehia Ashwini Davison MD Stephen Sisson MD 《The American journal of medicine》2009,122(7):629-631
78.
Background
Whole body vibration (WBV) exposure at work is common and studies found evidence that this exposure might cause low back pain (LBP). A recent review concluded there is a lack of evidence of effective strategies to reduce WBV exposure. Most research in this field is focussed on the technical implications, although changing behaviour towards WBV exposure might be promising as well. Therefore, we developed an intervention programme to reduce WBV exposure in a population of drivers with the emphasis on a change in behaviour of driver and employer. The hypothesis is that an effective reduction in WBV exposure, in time, will lead to a reduction in LBP as WBV exposure is a proxy for an increased risk of LBP. 相似文献79.
80.
The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic 总被引:1,自引:0,他引:1
BACKGROUND: The objective of the study was to assess the effectiveness of intradermal (ID) rabies vaccination and to determine whether any difference in response with age or gender exists. No published Australian data on the subject is available and controversy continues to surround the use of ID rabies vaccination for pre-exposure prophylaxis. Vaccinated travelers requiring postexposure treatment are sometimes considered unvaccinated. By confirming their immunity prior to travel, this problem may be avoided. METHODS: The data was collected by retrospective analysis over 2 years at a specialized travel medicine clinic in Perth, Western Australia. The standard protocol is three ID injections of 0.1 mL, given on days 0, 7, and 28 with a booster after 12 months. The vaccine used was the Pasteur Merieux human diploid cell vaccine. Serology was performed 3 weeks after completion of the primary course or after a booster. Antibody levels were measured using the rapid fluorescent focus inhibition test, and levels of >0.5 IU/mL were considered protective. RESULTS: A total of 164 travelers were included in the study, of which 144 had completed the three primary ID doses, and 20 had received an ID booster after a previous primary ID course. The mean age was 34.75 years, and gender distribution was equal. The median time between vaccination and serology was 23 days. The antibody levels ranged from 0 to 50 IU/mL with a mean of 8.42 IU/mL. Three travelers had no detectable antibodies giving a seroconversion rate of 98.2%. No statistically significant correlation between age or gender and antibody levels was present. CONCLUSION: We have found that ID rabies vaccination is effective in a travel clinic with nurses experienced in the technique. The lower cost of ID rabies vaccination makes it accessible to a larger number of travelers. Further studies will be required to determine the duration of protection after ID vaccination and antibody response after postexposure boosters. We will continue to recommend ID rabies vaccination if there is sufficient time for serology to be performed and for results to be available prior to departure. 相似文献